Sign In
Buy ZTS
$79.52
+1.93 (+2.49%)
At Close: Jun 04, 2026
LOS ANGELES, CA / ACCESSWIRE / April 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zo
1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation
07:00am, Tuesday, 30'th Apr 2024
Zoetis is the leader in the global animal healthcare industry. However, it has run into a trio of short-term issues.
Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics
10:22am, Monday, 29'th Apr 2024
Besides Wall Street's top -and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Wall Street Analysts Look Bullish on Zoetis (ZTS): Should You Buy?
10:31am, Friday, 26'th Apr 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
07:21pm, Monday, 22'nd Apr 2024
In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.
Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks
07:00am, Thursday, 18'th Apr 2024
Short-term bonds currently yield more than stocks, indicating a shift in the investment environment. Investors should focus on companies with healthy balance sheets, pricing power, and that are tradin
Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
09:27pm, Sunday, 14'th Apr 2024
Zoetis Inc. has seen a significant decline in its stock price, dropping more than 24% since January. The decline is partly due to market weakness and the ongoing growth to value rotation, as well as h
Zoetis shares drop amid concerns over arthritis shots' safety for pets
12:32pm, Friday, 12'th Apr 2024
Zoetis Inc (NYSE:ZTS, ETR:ZOE) shares took a hit Friday after a Wall Street Journal report that suggested the company's arthritis shots may have sickened dogs and cats. The arthritis shots, Librela an
Zoetis Stock Falls on Concerns Over Pet Arthritis Drugs. Company Says They're Safe.
11:24am, Friday, 12'th Apr 2024
An article in The Wall Street Journal highlights the scrutiny over the company's arthritis treatments for pets.
Zoetis's stock falls 7% to lead S&P 500 decliners after report its arthritis shots have sickened pets
11:20am, Friday, 12'th Apr 2024
Zoetis Inc.'s stock ZTS, -7.77% tumbled 7% Friday to lead S&P 500 decliners, after a Wall Street Journal report that the company's arthritis shots Librela and Solensia may have sickened pet cats and d
Why Zoetis (ZTS) Dipped More Than Broader Market Today
07:21pm, Monday, 08'th Apr 2024
The latest trading day saw Zoetis (ZTS) settling at $165.69, representing a -0.1% change from its previous close.
My Top 15 High Growth Dividend Stocks For April 2024
01:47pm, Monday, 01'st Apr 2024
The SPDR S&P 500 ETF Trust had a 3.27% return in March, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for April 2024 offer an average dividend
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks of March?
03:10am, Monday, 01'st Apr 2024
Lululemon offered weaker-than-expected guidance in its fourth-quarter earnings report. Southwest cut its guidance in response to the crisis at Boeing.
Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results
08:30am, Thursday, 28'th Mar 2024
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024. Chief Executive Officer Kristin Pec
You Don't Have To Take Excess Risk To Beat The Market
05:59pm, Monday, 25'th Mar 2024
It is possible for retail investors to consistently beat the market by owning above-average blue chip dividend growth stocks. Hard work, research, and staying rational are key factors in outperforming
